← Leaderboards
Xiangxi Mike Xu
University Of Miami School Of Medicine
$16,938,053
Attributed
$17,201,178
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,201,178 · 8
By mechanism
R01$15,337,726 · 6
P50$1,468,765 · 1
R21$394,687 · 1
Top collaborators
- Ralf Paus1 shared
- Tongyu Cao Wikramanayake1 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Ralf Paus$785,012
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMalignant Neoplasm Of OvaryOvarianSurfaceMouse ModelEpithelial CellsOvarian NeoplasmTumorEpithelialInvestigationMolecularMutationPhenotypeBiologyTissuesLeadGrowthCultured CellsTp53 GeneBasement MembraneEpitheliumInsightBaseEvent
Grant awards (60)
Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy$351,131
R01 · FY2025 · CA · contact PI
Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy$351,131
R01 · FY2024 · CA · contact PI
Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia$394,687
R21 · FY2023 · CA
Ovarian Epithelial Cancer Progenitor Cell Population$344,109
R01 · FY2022 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$46,541
R01 · FY2022 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$556,445
R01 · FY2021 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$351,131
R01 · FY2020 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$157,823
R01 · FY2020 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$340,596
R01 · FY2019 · CA · contact PI
Ovarian Epithelial Cancer Progenitor Cell Population$351,131
R01 · FY2018 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$326,412
R01 · FY2015 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$364,927
R01 · FY2014 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$316,620
R01 · FY2014 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$353,498
R01 · FY2013 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$306,828
R01 · FY2013 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$48,057
R01 · FY2013 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$375,915
R01 · FY2012 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$326,412
R01 · FY2012 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$30,548
R01 · FY2012 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$375,772
R01 · FY2011 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$326,412
R01 · FY2011 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$400,502
R01 · FY2010 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$323,942
R01 · FY2010 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$307,831
R01 · FY2009 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$85,680
R01 · FY2009 · CA · contact PI
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention$603,663
P50 · FY2008 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$326,412
R01 · FY2008 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$323,942
R01 · FY2008 · CA · contact PI
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention$590,659
P50 · FY2007 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$421,256
R01 · FY2007 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$360,547
R01 · FY2007 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$225,090
R01 · FY2007 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$136,963
R01 · FY2007 · CA · contact PI
Gonadotropins & Cox-2 in Ovarian Cancer Prevention$422,115
R01 · FY2006 · CA · contact PI
Epithelial Positioning Organization and Ovarian Cancer$372,866
R01 · FY2006 · CA · contact PI
Ovarian Cancer: Epithelial Dedifferentiation$371,315
R01 · FY2006 · CA · contact PI
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention$96,660
P50 · FY2006 · CA · contact PI
Gonadotropins &Cox-2 in Ovarian Cancer Prevention$420,589
R01 · FY2005 · CA
Ovarian Cancer: Epithelial Dedifferentiation$380,250
R01 · FY2005 · CA
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention$88,942
P50 · FY2005 · CA
Gonadotropins &Cox-2 in Ovarian Cancer Prevention$410,839
R01 · FY2004 · CA
Ovarian Cancer: Epithelial Dedifferentiation$382,500
R01 · FY2004 · CA
Epithelial Positioning Organization and Ovarian Cancer$373,800
R01 · FY2004 · CA
Epithelial Positioning Organization and Ovarian Cancer$127,853
R01 · FY2004 · CA
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention$88,841
P50 · FY2004 · CA
Gonadotropins &Cox-2 in Ovarian Cancer Prevention$406,010
R01 · FY2003 · CA
Epithelial Positioning Organization and Ovarian Cancer$373,800
R01 · FY2003 · CA
OVARIAN CANCER$347,668
R01 · FY2003 · CA
Epithelial Positioning Organization and Ovarian Cancer$124,129
R01 · FY2003 · CA
Epithelial Positioning Organization and Ovarian Cancer$374,915
R01 · FY2002 · CA
OVARIAN CANCER$266,465
R01 · FY2002 · CA
Epithelial Positioning Organization and Ovarian Cancer$94,503
R01 · FY2002 · CA
OVARIAN CANCER$76,497
R01 · FY2002 · CA
DAB2 AND RAS REGULATION$270,231
R01 · FY2001 · CA
OVARIAN CANCER$262,862
R01 · FY2001 · CA
OVARIAN CANCER$12,500
R01 · FY2001 · CA
DAB2 AND RAS REGULATION$263,886
R01 · FY2000 · CA
OVARIAN CANCER$174,146
R01 · FY2000 · CA
OVARIAN CANCER$60,550
R01 · FY2000 · CA
OVARIAN CANCER$53,833
R01 · FY2000 · CA